OBJECTIVES: Postoperative left atrioventricular valve (LAVV) dysfunction is known to be the principal risk factor influencing outcome after repair of all types of atrioventricular septal defect (AVSD). The purpose of the present study was to identify the risk factors for reoperation and to assess the outcomes after reoperation for LAVV dysfunction.
INTRODUCTION
Atrioventricular septal defect (AVSD) defines endocardial cushion defects resulting in various degrees of absence of septal development in both atrial and ventricular levels. These defects fall in a spectrum of severity from partial, intermediate (or transitional) to complete AVSD ( p-AVSD, i-AVSD and c-AVSD, respectively). Anatomical repair requires the presence of two 'adequate' ventricles and consists of the closure of septal defects associated with reconstruction of two functional atrioventricular valves.
During the last decades, surgical outcome has improved and primary repair in early infancy is nowadays commonly performed. However, postoperative left atrioventricular valve (LAVV) dysfunction influences outcome and constitutes the principal cause for reoperation [1] [2] [3] . Preoperative LAVV regurgitation (LAVVR) [4] [5] [6] , incomplete cleft closure [7] , double orifice LAVV [6] , associated cardiovascular anomalies [8] and normal karyotype [9, 10] have been identified as risk factors for LAVV dysfunction and reoperation. Nevertheless, reoperation for LAVV dysfunction still remains a surgical challenge: repair techniques are not well established and valve replacement is associated with poor outcome [11] .
The aim of this study was to identify the risk factors for mortality and LAVV reoperation in a consecutive single-centre patient cohort. In addition, the outcome after surgical management of LAVV dysfunction was assessed.
PATIENTS AND METHODS

Patients' characteristics
The records of all patients undergoing initial AVSD repair between January 2000 and July 2012 were reviewed. Data were collected from hospital records, echocardiographic studies, operative reports and referring paediatric cardiologists' reports. Because of the retrospective nature of the study, individual patient consent was waived.
Inclusion criteria were patients with partial, intermediate or complete AVSD ( p-AVSD, i-AVSD and c-AVSD, respectively) who underwent their first surgical biventricular repair at our institution. The distinction between i-AVSD and other forms was essentially based on the presence of a restrictive interventricular shunt in preoperative or previous echocardiographies, virtually occluded by the edges of bridging leaflets. Patients with associated tetralogy of Fallot, double-outlet right ventricle or with hypoplastic left or right ventricle or other major cardiovascular anomalies, and who therefore were directed towards a single ventricle palliation, were not included.
Demographic and clinical characteristics of the patients who underwent initial repair are listed in Table 1 .
Relative hypoplasia of one ventricle (unbalanced ventricles) was defined according both non-apex-forming aspect of the 'small' ventricle in echocardiography and, more recently, atrioventricular valve index (AVVI) (LAVV area/total atrioventricular valve area, centimetres squared) being <0.4 (hypoplastic left) or >0.6 (hypoplastic right) [12] . Left or right hypoplastic ventricle was found in 33 and 16 patients, respectively.
Surgical technique
Six surgeons were involved in the studied procedures. Primary AVSD repair for c-AVSD and i-AVSD was performed through median sternotomy. In selected patients, p-AVSD repair was performed through postero-lateral thoracotomy for aesthetic reasons.
Initial repair was performed using standard techniques related to the type of defect present. c-AVSDs were repaired with a twopatch technique, but with different patch materials according to the surgeon's preference. In i-AVSD, the VSD, if still patent, was directly closed by the free edges of the bridging leaflets. Primum defects were closed with a single-patch in all p-AVSD. Coronary sinus was almost always left in the right atrial side.
The cleft was directly and entirely (or as much as possible) closed [13] . To avoid excessive tension and optimal leaflet mobility, secondary chordae division was commonly performed. At initial repair, because of the hypoplasia of the left component of the common AV valve, the cleft was left open or incompletely closed in 72 patients (20.5%).
LAVV reoperations were performed through median redo sternotomy. The approach to the LAVV was performed through right atriotomy, by lateral detachment of the ASD patch in early (in-hospital), and through left atriotomy at the level of the Sondergaard sulcus in late reoperations. The LAVV was exposed by means of stay sutures placed at each commissure and the functional anatomy was explored at three levels: annulus, leaflet and subvalvular apparatus. The repair is oriented in light of both preoperative echocardiography and the intraoperative findings. The annular deformity or dilatation was treated by single or multiple pledgeted annuloplasty stitches placed at the commissural and posterior annulus. In 6 patients, an incomplete prosthetic annuloplasty device was used. The subvalvular apparatus is rehabilitated in order to improve leaflet mobility by means of section of secondary attachments, chordae/papillary muscle splitting and, if necessary division. Cleft dehiscence, if present, was more likely closed directly. In the presence of leaflet prolapse, artificial PTFE chordae were more likely used. In the presence of associated restrictive valve opening, the latter was improved by the creation of commissures, if necessary supported by additional artificial chordae. When the annular plication and the subvalvular apparatus rehabilitation failed to obtain a satisfactory valve competence using the saline test or at perioperative transoesophageal echocardiography, the anterior leaflet was augmented using a fresh autologous pericardial patch. Repairs always aimed at the creation of a durable functional anatomy were performed. Perioperative transoesophageal echocardiography was routinely performed in order to evaluate valve repair. The repair was considered successful if mild or less residual regurgitation and mean trans-valvular gradient <7 mmHg were present.
All procedures were performed under normothermic continuous cardiopulmonary bypass, and myocardial protection was achieved by intermittent antegrade warm blood cardioplegia. model was expressed by the odds ratio (OR) with their 95% confidence intervals (CIs). Estimates of overall survival were obtained by means of the actuarial method, with differences in survival between patients who underwent reoperation or not being tested by the log-rank (Mantel-Cox) test. Overall freedom from reoperation after initial repair included deaths to form a composite endpoint and the difference between early and late reoperation was tested by the log-rank test. P-values of <0.05 were considered statistically significant.
Statistical methods
RESULTS
The follow-up began at the date of the first AVSD repair, and the date of censoring was 31 August 2012. The median follow-up was 60 months [interquartile 68] (range 1-150). At initial repair, the median age was 6.9 months (range: 36 days to 59.7 years) and the median weight was 5.5 kg (2.6-96.0 kg).
Reoperations
Of 412 patients who underwent anatomical repair for AVSD repair between January 2000 and July 2012, 47 (11.4%) underwent 64 reoperations for LAVV dysfunction. The 365 who did not need reoperation for LAVVR were considered as the control group to identify risk factors for reoperation. The study group also included 13 additional patients for whom initial AVSD repair was performed in a primary institution. A total of 82 reoperations were required on these 60 patients. Therefore, the study group for LAVV reoperation included 60 patients: 52 (87%) of them presented with isolated LAVVR, 2 (3%) isolated stenosis and, the remaining (n = 6, 10%), both stenosis and regurgitation.
The median age at reoperation on the left atrioventricular valve was 11.6 months (range: 2.1 months to 25.3 years). The median interval from initial AVSD repair was 3.5 months (range: 5 days to 10.0 years). Demographic and clinical characteristics of the reoperated patients are listed in Table 2 .
Twenty-four [6% (24/412) and 40% (24/60)] required reoperation within the month following repair. Forty-one patients underwent a single LAVV reoperation, 18 underwent 2 and 4 underwent 3: native LAVV preservation was obtained in 43 patients (71.7%). At first reoperation, 54 repairs (90%) and 6 replacements (10%) were performed. Half of the subsequent reoperations for LAVVR ended up in valve replacement. A total of 17 LAVV was replaced. The presence of preoperative LAVV stenosis (n = 8) did not influence outcome. Patients for whom the native valve was preserved presented with moderate or less LAVVR/stenosis at last control. Table 3 represents independent risk factors for LAVV reoperation. In multivariate analysis, double-orifice LAVV (OR = 5.04, 95% CI: 1.39-18.27, P = 0.014), unbalanced ventricles with small left ventricle (OR = 4.06, 95% CI: 1.58-10.44, P = 0.004), prior palliative surgery (OR = 3.5, 95% CI: 1.14-10.8, P = 0.029) and discharge echocardiography documenting LAVVR grade >2 (OR = 21.96, 95% CI: 8.91-54.09, P < 0.001) were found to be independent risk factors for LAVV reoperation. .09, P < 0.001) were found to be independent risk factors for mortality. Table 5 summarizes the causes of mortality. Valve-related death was found to be the most common cause of death [40% (6/15)]. Within the study group including patients reoperated on for LAVV dysfunction, 8 patients died (13%). All these deaths are detailed in Table 5 . Six of them (6/8) had required early reoperation within the 2 months following repair. Five of 6 had their LAVV replaced at reoperation.
Only 1 late (>1 year) death occurred in 1 partial AVSD patient 5 years after anatomical repair and 2.6 years after the last reoperation. This patient had undergone two LAVV repairs for LAVVR in a 3-month time interval, the last because of common anterior leaflet augmentation patch dehiscence. Cause of death was heart failure by major biventricular dysfunction due to left coronary artery thrombosis, despite 2 weeks of extra-corporal membrane oxygenation support.
Complications due to valve replacement were cause of death in 5/8 patients in the reoperation group.
Survival
Overall survival in all cohorts was 96.5% at 1 year and 96.1% at 5 and 10 years. There was a significant difference in survival at 12 years between patients who were reoperated or not for LAVV dysfunction (P < 0.001) (Fig. 1) . Overall freedom from LAVV reoperation after initial repair was 93.3, 87.3 and 85.8% at 1, 5 and 10 years, respectively. Regarding the study group (n = 60), survival after the first LAVV reoperation in the year following anatomical repair was significantly worse compared with patients who required late (>1 year) LAVV reoperation (P = 0.020) (Fig. 2A) . Need for early (subsequent) reoperation was also associated with poor outcome (P = 0.005) (Fig. 2B) . Finally, there was also a statistically significant difference in survival between patients who underwent valve repair or replacement (P = 0.020) (Fig. 3) .
DISCUSSION
Our initial aim in elaborating the present study was to give an objective and valuable tool to the paediatric cardiologist for prenatal counselling: a consecutive unselected cohort of patients presenting with different morphological types of AVSD were repaired using current indications for surgery and surgical techniques. The overall outcomes were satisfactory and the failures were mainly subsequent to postoperative LAVV dysfunction. A relatively significant percentage (10%) required reoperation for LAVV dysfunction, almost always dominated by regurgitation. Need for early LAVV reoperation was associated with poor outcome; however, the results of late LAVV reoperations were encouraging, as well as the rate of native valve preservation in this population: 85%. Twelve-year survival rates were 96.5% at 1 year and 96.1% at 5 and 10 years, and reached 98% when the repair resulted in a functional LAVV. Several risk factors for both mortality and need for LAVV reoperation were analysed. Some of the findings were discordant with the 'intuitions' or 'convictions' common in our community, while others confirmed current strategies. The subtype of AVSD did not influence outcome despite the tendency for earlier repair in the presence of an inter-ventricular shunt. Normal karyotype, associated with poorer LAVV functional outcome (P = 0.008 in univariate analysis), was not an independent risk factor either for mortality or for reoperation [9, 10] . Although the obligation for anatomical repair in early infancy because of refractory heart failure was associated with a higher risk of death and reoperation in univariate tests, delaying the repair by performing a palliation was an independent risk factor for both mortality and need for LAVV reoperation (Tables 4 and 5 ). Unbalanced ventricles, double orifice LAVV confirmed their bad reputation associated with poorer outcomes [14, 15] . The higher rate of need for reoperation in these two subsets was obviously due to the inability to close the cleft entirely.
Surgical techniques have evolved in time, and the section of secondary attachments under both bridging leaflets has become routine. The aim of this technical modification was to obtain optimal leaflet mobility and, also, to avoid excessive tension on the cleft's edges and subsequent cleft dehiscence, a well-known reason for reoperation [14, 16] .
Three different surgical techniques for initial repair of c-AVSD had already been described: single-patch, two-patch and modified onepatch techniques [17] . In their study, Krasemann et al. [18] showed no significant difference in the degree of LAVVR between the different techniques. Tweddell et al. [19] identified the one-patch repair as a risk factor for late LAVVR by univariate analysis but not by multivariate analysis. In our series, the double-patch technique was performed in all our patients who presented with c-AVSD.
Primary anatomical repair at any age instead of initial palliative pulmonary artery banding for symptomatic newborns and young infants is debatable. Despite being more demanding in terms of surgical technique, the age and the weight at repair did not appear to be risk factors influencing outcome. On the other hand, palliation is not a valuable option when the clinical intolerance is due to common AV valve regurgitation. In case of suitable intracardiac anatomy with balanced ventricles and left-sided atrioventricular leaflet material at preoperative echocardiography, primary repair was routinely performed.
Reoperation for LAVV dysfunction after AVSD repair remains a surgical challenge. Valve replacement carries a high incidence of morbidity and mortality [11] . Some authors have identified valve replacement as a significant risk factor for early death [20] . Our experience confirmed the disastrous consequences of need for early LAVV reoperation leading to valve replacement (Table 5) .
Sixty patients underwent a total of 82 reoperations: 52 (87%) of them presented with isolated LAVVR, 2 (3%) isolated stenosis and, 71.8% at 1 year, 2, 3, 5, 10 and 12 years (95% CI: 52.6-91.0%). In the late reoperation group: 97.3% at 1 and 2 years (95% CI: 92.0-100%), 92.3% at 3, 5, 10 and 12 years (95% CI: 81.5-100%). P = 0.020. (B) Survival with freedom from subsequent reoperation after first reoperation (n = 60). In early (<1 year) reoperation group: 59.1% at 1 year (95% CI: 33.7-75.4%), 49.8% at 2 years (95% CI: 28.8-70.8%), 44.8% at 3 years (95% CI: 23.8-65.8%), 39.2% at 5, 10 and 12 years (95% CI: 18.1-60.3%). In the late (>1 year) reoperation group: 88.6% at 1 year (95%CI: 78.1-99.2%), 80.6% at 2 years (95% CI: 66.3-94.9%), 76.0% at 3 and 5 years (95% CI: 59.9-92.1%) and 68.4% at 10 and 12 years (95% CI: 48.2-88.6%). P = 0.005. 
CONGENITAL
the remaining (n = 6, 10%) both stenosis and regurgitation. Native LAVV preservation was allowed in 43 (71.7%) patients undergoing reoperation. These results are comparable to those of Malhotra et al. [21] who presented with a 71.4% rate of freedom from prosthetic replacement. Valve-related complications were the cause of death in 5 of the 8 patients who died in this group. Survival was statistically different at 12 years between patients who underwent valve repair or replacement (93 vs 70.6%, P = 0.013). These figures are comparable to the results of Patel et al. [22] who identified a 6% in-hospital mortality rate after LAVV repair reoperation and a 30% in-hospital mortality rate after LAVV replacement reoperation. Regarding long-term survival, Hoohenkerk et al. [8] reported that overall survival at 10 and 15 years after reoperation was significantly higher after LAVV repair than after replacement in a 45 different AVSDs population, whereas Stulak et al. [23] reported no significant difference in 20-year survival in a 64 p-AVSD population. Despite the functional anatomical variability of the lesions, the surgical valve repair techniques were more or less standardized in order to obtain an optimal valve coaptation as well as opening. Segmental annuloplasty, subvalvular apparatus debridement and splitting, chordae repair and leaflet patch augmentation techniques were commonly used. The repair was intraoperatively evaluated by transoesophagial echocardiography. Suboptimal intraoperative LAVV repair results predicting the need for further procedure were accepted in younger patients when associated with stable haemodynamics.
During the study period, from the cohort, 3 patients underwent reoperation for subaortic stenosis release that was associated with LAVV repair in one. In 4 other patients, reoperations for right AVV repair were performed. No other anomaly specific reoperations were documented.
This retrospective study has the limitation of associating a consecutive series of all types of AVSD. Specific analyses of all anatomical subtypes have also been performed without any additional significant result. On the other hand, the study has a '2 in 1' character by the evaluation of the results and outcomes after LAVV reoperation in the current era. The 13 patients not primarily operated on in our hospital were not considered for risk-factor analysis but only for outcome analysis following LAVV reoperation.
CONCLUSION
A consecutive and representative series of AVSD was analysed. Risk factors for both reoperation and death were identified. The outcome was influenced mainly by postoperative LAVV function: survival was poorer for patients who underwent LAVV reoperation and further valve replacement. The need for mechanical valve prosthesis was rare: valve preservation was obtained in 71.7%, with an estimated overall survival of 93% at 10 years after reoperation.
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APPENDIX. CONFERENCE DISCUSSION
Dr B. Kreitmann (Marseille, France): One of the difficult decisions to make, and one of the key points for both repair or re-repair, is how small the left AV orifice can be. How far do you think we can go to in terms of z-score or per-operative gradient by TOE and/or anaesthesia, or postoperative gradient after the patient is awake? We have a lot of studies and data from the adult population with cardiomyopathy where we do restrictive annuloplasty or any other kind of plasty, but then we really need data from that. And so I would ask you, how small is too small for the left AV valve orifice?
Dr Pontailler: I would prefer that Dr. Belli answer this question. Dr Belli: It is a very good question. It is always difficult to decide how far we can go to reduce the annulus or the valve orifice. We observe often in reoperated patients, where we find a hole both stenosed and leaking because during the previous procedure the valve was closed as much as judged sufficient to accept systemic flow, and in order to avoid regurgitation. There is a big difference between leaflet closure and annular reduction. We can say, in our practice, we are going to a minus 2 mm theoretical value of the Hagar dilator corresponding to the weight of the patient. Minus 2 mm, we can easily go on to that diameter.
Dr A. Amirghofran (Shiraz, Iran): I wanted to ask you, what was the main cause of regurgitation in these 47 patients you had that needed reoperation, because mostly it is said, and our observation has shown, that reopening of the cleft and also dilatation of the annulus, re-dilatation of the annulus, are the main causes. Thus I wanted to see what was the main cause in your series. And for annular dilatation, what do you do, how do you do the annuloplasty? Is it by Gore-Tex tape or by ring, or whatever?
Dr Belli: The most frequent reason for the reoperations was, of course, due to early failure caused by the dehiscence, or early functional deterioration of the reconstructed left AV valve. How to manage the valve in a late reoperation? Independently of the age of the patient, there are several options for annular plication and not remodelling: there is no annuloplasty device conceived for the shape of the left AV valve in AVSD. So what we do is to reduce two-thirds of the circumference from septum to septum, even less, in order to avoid AV block. Finally, what we perform in young patients is simple stitches on the annulus, not only the commissures, and in larger patients we use some prosthetic devices, including the Medtronic open ring or, more recently, the Uniring, which is obviously adapted for older congenital patients.
Dr A. Takriti (Damascus, Syria): How often do you liberate the secondary tendineae and split the papillary muscle, and do you use a patch to close the cleft sometimes, especially in reoperations?
Dr Belli: This technique to improve leaflet mobility has arisen from the concern to avoid subaortic stenosis, which is obviously a very rare complication. In this series we should have one or two patients who underwent a reoperation for subaortic stenosis. On the other hand, in the '90s and '80s there was a relatively high rate of reoperation for cleft dehiscence; this strategy also aimed to diminish stress on cleft edges, based on our experience with mitral valve repair in the congenital population. We performed it as much as possible, mainly in patients with a restrictive posterior bridging leaflet, and eventually in some patients we went as far as transforming from type A, by removal of all the chordae attaching the free edge of the anterior bridging leaflet in order to adjust in a two-dimensional way, for a better leaflet coaptation postoperatively.
Dr Takriti: And for the patch, do you use a patch all the time? Dr Belli: A patch is exceptional in first repair; in this series there must be two patients. In reoperation, in particular in older patients, we will more likely use a fresh autologous pericardium patch in order not to reduce the leaflet opening too much and to obtain coaptation, with satisfactory mid-term results.
Dr D. Barron (Birmingham, UK): Just to go back to the primary repair, I was intrigued by you dividing the secondary chords, because we are taught by the adult mitral surgeons that the secondary chords are very important for maintaining valve performance in the long term, but you think we should do it for all the patients, divide the secondary chords?
Dr Belli: There is a paper by Anderson and the London team, suggesting that the secondary chordae and cleft closure technique results in better left AV valve outcome. Probably we are against it. We didn't do a randomized series, but obviously there is no more cleft dehiscence in our series since we did that, and at least one risk factor has been removed. As you know, the left AV valve in AVSD is not a normal mitral valve, we cannot transpose these theories, more or less based on a hypothesis to be confirmed on this anomaly. So we try to have a good postoperative valve function on echo and will see better in the long-term follow-up.
CONGENITAL
